↓ Skip to main content

Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases

Overview of attention for article published in Frontiers in Pharmacology, October 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases
Published in
Frontiers in Pharmacology, October 2021
DOI 10.3389/fphar.2021.761842
Pubmed ID
Authors

Kazuhiko Fukushima, Shinji Kitamura, Kenji Tsuji, Jun Wada

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 20%
Unspecified 2 10%
Lecturer 2 10%
Other 1 5%
Student > Bachelor 1 5%
Other 4 20%
Unknown 6 30%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 30%
Biochemistry, Genetics and Molecular Biology 2 10%
Unspecified 2 10%
Arts and Humanities 1 5%
Agricultural and Biological Sciences 1 5%
Other 1 5%
Unknown 7 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2022.
All research outputs
#7,599,335
of 23,310,485 outputs
Outputs from Frontiers in Pharmacology
#3,381
of 16,763 outputs
Outputs of similar age
#152,724
of 439,690 outputs
Outputs of similar age from Frontiers in Pharmacology
#202
of 1,123 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 16,763 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,690 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.